Skip to content

Obstructive Sleep Apnea Among Somali-Americans

Evaluating the Prevalence and Implications of Obstructive Sleep Apnea Among Somali-Americans: A Translational Research Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04124848
Acronym
Somali OSA
Enrollment
600
Registered
2019-10-11
Start date
2019-10-25
Completion date
2031-12-31
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Somali-Americans, Sleep Disordered Breathing, Cardiovascular Diseases, Sex and Racial Differences, Respiratory Disorders, Hypertension, Diabetes, Health Disparities

Brief summary

The investigators seek to advance the understanding of obstructive sleep apnea as it relates to different ethnic origins as well as sex differences. The investigators will compare Somali patients with known obstructive sleep apnea (OSA) to individuals without OSA, and to individuals of other ethnic/racial origins to determine the risk factors (genetic and/or physiologic) associated with developing cardiovascular diseases. This will help the investigators to understand the unique sleep pathology of individuals of African descent.

Detailed description

Participants can be healthy volunteers or volunteers diagnosed with obstructive sleep apnea. All patients may undergo a sleep study (i.e. hospital or home-based), physical examination, questionnaires, blood and urine samples, ultrasound scan of the heart and brachial artery in the arm, CT scan, DEXA scan, paced breathing test, cardiopulmonary test and chemo-sensitivity test.

Interventions

None listed

Sponsors

Sleep Number Corporation
CollaboratorUNKNOWN
Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Self-identify as Somali, African, Asian, and European descent. * Adult males and females who are older than 18 years of age.

Exclusion criteria

* Minors under 18 years or adults over 100 years * Positive pregnancy

Design outcomes

Primary

MeasureTime frameDescription
To assess the prevalence of obstructive sleep apnea10 yearsMeasure the apnea-hypopnea index (AHI) to determine burden of obstructive sleep apnea. Based on the AHI, sleep apnea will be diagnosed if the AHI is ≥5 events/hour.
To determine the severity of obstructive sleep apnea10 yearsThe severity of OSA is classified based on the AHI as follows: None/Minimal: AHI \< 5 per hour, Mild: AHI ≥ 5, but \< 15 per hour, Moderate: AHI ≥ 15, but \< 30 per hour, Severe: AHI ≥ 30 per hour.

Secondary

MeasureTime frameDescription
Vascular endothelial function10 yearsChange in brachial artery diameter in response to hyperemia
Insulin sensitivity10 yearsOral glucose tolerance testing
Body composition10 yearsPercentage body fat content
24 hour mean arterial pressure10 yearsAmbulatory measure of blood pressure in mmHg

Countries

United States

Contacts

Primary ContactSomers CPL Lab
CPLSOMALI@mayo.edu507-422-3499

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026